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Results
Research Protections Acceptance
Class projects require that the instructor develop a method of determining that the 
projects meet the required criteria to be "exempt" from Committee review. The 
requirements for this course have been reviewed and accepted by the UVM Office 
of Research Protections. 
Subjects & Data Collection
• 91 subjects at syringe exchange programs run by Vermont CARES at permanent 
sites in St. Johnsbury and Rutland and a mobile clinic serving greater Vermont
• 20 item survey aimed at identifying general health practices and barriers to 
receiving healthcare for intravenous drug users who participate in a syringe 
exchange program
Statistical Analysis
• 2-Tailed Fischer’s exact tests were conducted with graphpad.com statistical 
software
Methods
1) Assess the impact of VT CARES syringe exchange program on the health of their 
participants  
2) Compare healthcare service usage in long-term and new syringe exchange 
participants
3) Determine how VT CARES could improve its syringe exchange program
Aims
We would like to express our gratitude to Dr. Thomas Delaney for his help with statistical analysis, Dr. Jan Carney 
for her assistance in public health research, and to the VT CARES staff for their help in administering and 
collecting surveys. 
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• Long-term members compared to new members tended to have a primary care 
provider.  Most commonly cited reasons for not having a primary care provider 
included lack of insurance and fear of judgement.
• Long-term members were significantly less likely (p=0.04) to use costly ED/urgent 
care services. 
• Long-term members are less likely to reuse their own needle or one used by 
another person, suggesting the distribution of clean syringes at VT CARES 
encourages safe injection practices.
• Long-term members compared to new members are more likely to be in addiction 
treatment and reported a greater desire to abstain from drug use. This finding 
reflects the potential for positive personal change with sustained contact with 
syringe exchange programs. 
• New members are more likely to obtain hepatitis C/HIV testing in the past year. 
Decreased testing among long-term members may reflect prior knowledge or 
awareness of their disease status. 
Limitations
• Study composed of a small sample size (n=91) from three polling sites.
• Not all respondents completed surveys in their entirety.
Conclusions
• Participants expressed interest in safe syringe injection clinics.
• A staffed, controlled environment for IVDUs to safely inject with sterile 
supplies.
• Such clinics would lead to decreased rates of adverse health outcomes 
including infection and overdose.
• The majority of respondents indicated interest in primary care services through 
VT CARES if they were offered.  This would allow access for those affected by the 
barriers stated above.
• As demonstrated by the efficacy of the syringe exchange programs, expansion to 
new locations and additional funding sources should be considered.
Future Directions
What is Syringe Exchange?
• Public health intervention where people who use drugs, referred to as 
Intravenous Drug Users (IVDU), are provided clean syringes in exchange for used 
syringes
• Services are provided nonjudgmentally to facilitate positive change as defined by 
the person who uses drugs
How effective is Syringe Exchange?
• Reduces transmission of HIV, hepatitis C, and other blood-borne pathogens1
• Participants more likely to engage addiction treatment services and reduce drug 
use2
Drug Use in Vermont
• More than 1500 opioid-related substance abuse treatment admissions in 20103
• Heroin & fentanyl-related fatalities have been rising since 20134
• 75 accidental & undetermined opioid fatalities in 20154
1. Wodak, A., & Cooney, A. (2004). Effectiveness of sterile needle and syringe programming in reducing 
HIV/AIDS among injecting drug users. Geneva: World Health Organization.
2. Hagan, H., McGough, J. P., Thiede, H., Hopkins, S., Duchin, J., & Alexander, E. R. (2000). Reduced injection 
frequency and increased entry and retention in drug treatment associated with needle-exchange 
participation in Seattle drug injectors. J Subst Abuse Treat, 19(3), 247-252. 
3. Data Brief: Vermont Drug Control Update- The White House. Retrieved September 4, 2016, from 
http://www.whitehouse.gov/sites/default/files/docs/state_profile_-_vermont.pdf
4. Vermont Drug-Related Fatalities 2010-2015. (2016) Retrieved September 4, 2016, from 
http://healthvermont.gov/research/documents/databrief_drug_related_fatalities.pdf
Duration of Syringe Exchange 
Membership
No. of Participants
(% of total)
Not part of an exchange
6 (6.59)
0-6 months 23 (25.27)
6-12 months 23 (25.27)
1-2 years 23 (25.27)
More than 2 years 16 (17.58)
Previously, with a different program 0 (0.00)
Table 1. Participant’s Duration of Membership in Vermont CARES 
Syringe Exchange Program
*New members were designated by membership ≤ 6mo
Demographic No. of New Members
(% of New Members)
No. of Long-term Members
(% of Long-term 
Members)
Age (y.o.)
18-25 6 (20.69) 7 (11.29)
26-35 9 (31.03) 22 (35.48)
35-45 10 (34.48) 17 (27.42)
45-55 2 (6.90) 12 (19.35)
Older than 55 0 (0.00) 0 (0.00)
Needle exchange site
Rutland 18 (62.07) 31 (50.00)
St. Johnsbury 7 (24.14) 17 (27.42)
Mobile Site 3 (10.34) 10 (16.13)
Primary insurance
Medicaid/Medicare 25 (86.21) 50 (80.65)
Employer 0 (0.00) 3 (4.84)
Uninsured 2 (6.90) 5 (8.06)
Other 1 (3.45) 1 (1.61)
Table 2. Participant Demographics
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Figure 5: Comparison of interest in use of safer injection sites 
between new and long-term members
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Figure 4: Interest in abstaining from IVDU 
between new and long-term members.
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Figure 2: Prevalence of HIV and hepatitis C testing 
within the last year
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Figure 3: Current enrollment in addiction 
treatment among new and long-term members  
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Figure 1: Emergency department usage (p = 0.04)
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